Related references
Note: Only part of the references are listed.Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain
Eric S. Mullins et al.
BLOOD (2009)
被撤回的出版物: Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality (Retracted article. See vol. 117, pg. 7188, 2011)
Frank Niessen et al.
BLOOD (2009)
A Profibrotic Effect of Plasminogen Activator Inhibitor Type-1 (PAI-1) in the Heart
A. K. M. Tarikuz Zaman et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2009)
Plasminogen Activator Inhibitor-1 Regulates Integrin αvβ3 Expression and Autocrine Transforming Growth Factor β Signaling
Benjamin S. Pedroja et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Severe deficiency of coagulation Factor VII results in spontaneous cardiac fibrosis in mice
H. Xu et al.
JOURNAL OF PATHOLOGY (2009)
Cardiovascular disease in patients with hemophilia
A. Tuinenburg et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice
Yanqing Gong et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
A viable mouse model of factor X deficiency provides evidence for maternal transfer of factor X
S. J. Tai et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
A urokinase-type plasminogen activator deficiency diminishes the frequency of intestinal adenomas in ApcMin/+ mice
V. A. Ploplis et al.
JOURNAL OF PATHOLOGY (2007)
TGF-β signaling in vascular fibrosis
Marta Ruiz-Ortega et al.
CARDIOVASCULAR RESEARCH (2007)
The development of cardiac fibrosis in low tissue factor mice is gender-dependent and is associated with differential regulation of urokinase plasminogen activator
Darren R. Davis et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation
Scott P. Levick et al.
JOURNAL OF IMMUNOLOGY (2007)
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
John P. Iredale
JOURNAL OF CLINICAL INVESTIGATION (2007)
Plasminogen activator inhibitor-1 and Restenosis
Nadish Garg et al.
CURRENT DRUG TARGETS (2007)
Targeting plasminogen activator inhibitor-1: Role in cell signaling and the biology of domain-specific knock-in mice
R. D. Balsara et al.
CURRENT DRUG TARGETS (2007)
A coagulation factor VII deficiency protects against acute inflammatory responses in mice
H. Xu et al.
JOURNAL OF PATHOLOGY (2006)
Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator
April Stempien-Otero et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A fibrinogen deficiency accelerates the initiation of LDL cholesterol-driven atherosclerosis via thrombin generation and platelet activation in genetically predisposed mice
Takayuki Iwaki et al.
BLOOD (2006)
Pericytes influence endothelial cell growth characteristics: Role of plasminogen activator inhibitor type 1 (PAI-1)
M McIlroy et al.
CARDIOVASCULAR RESEARCH (2006)
Recommendations for chamber quantification: A report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
RM Lang et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2005)
A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice
B Pedersen et al.
BLOOD (2005)
Conservation of critical functional domains in murine plasminogen activator inhibitor-1
Z Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Enhanced in vitro proliferation of aortic endothelial cells from plasminogen activator inhibitor-1-deficient mice
VA Ploplis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction
K Takeshita et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice
H Moriwaki et al.
CIRCULATION RESEARCH (2004)
Decreased mortality of ischaemic heart disease among carriers of haemophilia
A Srámek et al.
LANCET (2003)
A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis
YF Huang et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Reduction in fibrotic tissue formation in mice genetically deficient in plasminogen activator inhibitor-1
S Chuang-Tsai et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction
AT Askari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Tissue factor deficiency cause's cardiac fibrosis and left ventricular dysfunction
R Pawlinski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Impact of anesthesia on cardiac function during echocardiography in mice
DM Roth et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition
K Kaikita et al.
CIRCULATION (2001)
Raised blood pressure, not renin-angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats
JE Bishop et al.
CARDIOVASCULAR RESEARCH (2000)
Share Paper
